Table 4.
Effect of progesterone, nitric oxide (NO), and NAME on maspin synthesis in normal, progesterone receptor + (PR+), and PR– neutrophils
| Maspin(nM/6 × 109 cells) | |||
|---|---|---|---|
| NORMAL | PR+ | PR- | |
| Progesterone (25 nM) | 2.329 ± 0.012a | 1.138 ± 0.024b | 0 |
| NO (5 μM) | 2.752 ± 0.15ac | 1.821 ± 0.16bc | 0.692 ± 0.008c |
| Progesterone (25 nM) + NAME (10 mM) | 0 | 0 | 0 |
| NO (5 μM) + NAME (10 mM) | 2.752 ± 0.15 | 1.821 ± 0.16 | 0.692 ± 0.008 |
The neutrophil suspensions were prepared from the blood of patients with PR+ or PR– breast cancer and of age-matched normal female volunteers as described in the Materials and Methods section. The neutrophil preparations (6 × 109 cells/L) were suspended in Hank’s balanced salt solution (pH7.4) and treated with progesterone (25 nM) and, NO (5 μM). In a separate experiment, a neutrophil suspension was incubated with NAME (10 mM) and with either NO or progesterone. Results are mean ± SD of five different experiments in triplicate using blood of 15 patients with breast cancer and 15 normal female volunteers.
P<0.005, n=5;
P<0.005, n=5;
P<0.005, n=5.